These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9708640)

  • 1. Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.
    Zanon C; Durando A; Geuna M; Clara R; Mobiglia A; Massobrio M; Palestro G; Pourshayesteh A
    Am J Clin Oncol; 1998 Aug; 21(4):392-7. PubMed ID: 9708640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators.
    Ravdin PM; De Laurentiis M; Vendely T; Clark GM
    J Natl Cancer Inst; 1994 Dec; 86(23):1771-5. PubMed ID: 7966415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.
    Malmström P; Bendahl PO; Boiesen P; Brünner N; Idvall I; Fernö M;
    J Clin Oncol; 2001 Apr; 19(7):2010-9. PubMed ID: 11283134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
    Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flow cytometric DNA index can predict the presence of lymph node metastases in invasive ductal breast carcinoma.
    Mannweiler S; Tsybrovskyy O; Regauer S
    APMIS; 2002 Aug; 110(7-8):580-6. PubMed ID: 12390417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and reinforcement of the correlation of S-phase fraction with nodal metastases, tumor grade and tumor size in breast carcinoma patients in Pakistan.
    Bakhtawar H; Ali NM; Khan S; Aziz SA; Sliddiqui T; Pervez S
    Pathol Res Pract; 2001; 197(8):531-6. PubMed ID: 11518045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
    Pervez S; Khan MN; Nasir MI
    J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of axillary node dissection in patients with T1a and T1b breast cancer: Mayo Clinic experience.
    Mincey BA; Bammer T; Atkinson EJ; Perez EA
    Arch Surg; 2001 Jul; 136(7):779-82. PubMed ID: 11448390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.